EP1042674A4 - 148 menschliche sekretierte proteine - Google Patents

148 menschliche sekretierte proteine

Info

Publication number
EP1042674A4
EP1042674A4 EP98956146A EP98956146A EP1042674A4 EP 1042674 A4 EP1042674 A4 EP 1042674A4 EP 98956146 A EP98956146 A EP 98956146A EP 98956146 A EP98956146 A EP 98956146A EP 1042674 A4 EP1042674 A4 EP 1042674A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98956146A
Other languages
English (en)
French (fr)
Other versions
EP1042674A1 (de
Inventor
Ping Feng
Craig A Rosen
Steven M Ruben
Jian Ni
Ying-Fei Wei
Daniel R Soppet
Paul A Moore
Hla Kayw
David W Lafleur
Henrik S Olsen
Laurie A Brewer
Yanggu Shi
Reinhard Ebner
Paul Young
John M Greene
Kimberly A Florence
Charles Florence
D Roxanne Duan
Fouad Janat
Gregory A Endress
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1042674A1 publication Critical patent/EP1042674A1/de
Publication of EP1042674A4 publication Critical patent/EP1042674A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP98956146A 1997-10-24 1998-10-23 148 menschliche sekretierte proteine Withdrawn EP1042674A4 (de)

Applications Claiming Priority (35)

Application Number Priority Date Filing Date Title
US6308897P 1997-10-24 1997-10-24
US6309997P 1997-10-24 1997-10-24
US6311097P 1997-10-24 1997-10-24
US6338797P 1997-10-24 1997-10-24
US6309097P 1997-10-24 1997-10-24
US6309197P 1997-10-24 1997-10-24
US6278497P 1997-10-24 1997-10-24
US6314897P 1997-10-24 1997-10-24
US6310997P 1997-10-24 1997-10-24
US6310097P 1997-10-24 1997-10-24
US6309897P 1997-10-24 1997-10-24
US6311197P 1997-10-24 1997-10-24
US6308997P 1997-10-24 1997-10-24
US6310197P 1997-10-24 1997-10-24
US6309297P 1997-10-24 1997-10-24
US6338697P 1997-10-24 1997-10-24
US6309797P 1997-10-24 1997-10-24
US63110P 1997-10-24
US63098P 1997-10-24
US63387P 1997-10-24
US63111P 1997-10-24
US63100P 1997-10-24
US63092P 1997-10-24
US63148P 1997-10-24
US63097P 1997-10-24
US63090P 1997-10-24
US63089P 1997-10-24
US63099P 1997-10-24
US63386P 1997-10-24
US63109P 1997-10-24
US63088P 1997-10-24
US63101P 1997-10-24
US62784P 1997-10-24
US63091P 1997-10-24
PCT/US1998/022376 WO1999022243A1 (en) 1997-10-24 1998-10-23 148 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1042674A1 EP1042674A1 (de) 2000-10-11
EP1042674A4 true EP1042674A4 (de) 2005-03-23

Family

ID=27586006

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98956146A Withdrawn EP1042674A4 (de) 1997-10-24 1998-10-23 148 menschliche sekretierte proteine

Country Status (5)

Country Link
EP (1) EP1042674A4 (de)
JP (1) JP2003521865A (de)
AU (1) AU1273499A (de)
CA (1) CA2307320A1 (de)
WO (1) WO1999022243A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034623A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 29 human secreted proteins
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2363684A1 (en) * 1999-03-05 2000-09-08 Incyte Pharmaceuticals, Inc. Human secretory proteins
US6331413B1 (en) 1999-03-17 2001-12-18 Zymogenetics, Inc. Secreted salivary ZSIG63 Polypeptide
WO2000071581A1 (fr) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Nouveau polypeptide
FR2796652B1 (fr) * 1999-07-20 2003-03-21 Inst Nat Sante Rech Med Acides nucleiques codant pour des peptides possedant l'activite biologique de la sorbine
AU1922301A (en) * 1999-11-17 2001-05-30 Nyxis Neurotherapies, Inc. Differential gene expression in cancer
AU2001253487A1 (en) * 2000-04-13 2001-10-30 Millennium Pharmaceuticals, Inc. 23155 novel protein human 5-alpha reductases and uses therefor
EP1322657A4 (de) * 2000-09-12 2004-12-29 Human Genome Sciences Inc 22 humane sezernierte proteine
AU2003294236A1 (en) * 2002-10-25 2004-05-25 Five Prime Therapeutics, Inc. Methods of use for novel human polypeptides encoded by polynucleotides
TW201100090A (en) * 2009-04-01 2011-01-01 Oncotherapy Science Inc C6orf167 peptides and vaccines containing the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020398A1 (en) * 1994-01-27 1995-08-03 Human Genome Sciences, Inc. Human growth hormone
WO1996017931A1 (en) * 1994-12-09 1996-06-13 Human Genome Sciences, Inc. Human vascular ibp-like growth factor
WO1996039522A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human chemokine beta-11 and human chemokine alpha-1

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020398A1 (en) * 1994-01-27 1995-08-03 Human Genome Sciences, Inc. Human growth hormone
WO1996017931A1 (en) * 1994-12-09 1996-06-13 Human Genome Sciences, Inc. Human vascular ibp-like growth factor
WO1996039522A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human chemokine beta-11 and human chemokine alpha-1

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COLEMAN T A ET AL: "Production and purification of novel secreted human proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 190, no. 1, 29 April 1997 (1997-04-29), pages 163 - 171, XP004064398, ISSN: 0378-1119 *
DATABASE EM_HUM [online] EMBL; 25 July 1997 (1997-07-25), MUZNY ET AL.: "Human Xp22 BAC CT-285I15 ..........", XP002302095, retrieved from EBI accession no. HSAC2366 Database accession no. AC002366 *
MARY P: "Le boom des chimiokines", BIOFUTUR. LE MENSUEL EUROPEEN DE BIOTECHNOLOGY, EDITIONS SCIENTIFIQUES ELSEVIER, PARIS, FR, vol. 1997, no. 165, March 1997 (1997-03-01), pages 32 - 37, XP004279638, ISSN: 0294-3506 *
See also references of WO9922243A1 *

Also Published As

Publication number Publication date
JP2003521865A (ja) 2003-07-22
CA2307320A1 (en) 1999-05-06
AU1273499A (en) 1999-05-17
WO1999022243A1 (en) 1999-05-06
EP1042674A1 (de) 2000-10-11

Similar Documents

Publication Publication Date Title
EP1039801A4 (de) 207 menschliche sekretierte proteine
EP1000084A4 (de) 123 vom menschen abgesonderte proteine
EP1088071A4 (de) 94 sekretierte menschliche proteine
EP1100869A4 (de) 98 menschliche sekretierte proteine
EP1040117A4 (de) 110 menschliche sekretierte proteines
AU6552198A (en) 28 human secreted proteins
EP1078046A4 (de) 97 menschliche, ausgeschiedene proteine
EP1109821A4 (de) 49 human-sekretierte proteine
EP1140970A4 (de) 47 menschliche sekretierte proteine
AU6952998A (en) 20 human secreted proteins
EP1051426A4 (de) 67 menschliche sekretierte proteine
EP1064297A4 (de) 95 proteine menschlichen ursprungs
EP1005544A4 (de) 70 menschliche, sekretierte proteine
EP1019091A4 (de) 50 menschliche sekretierte proteine
EP1044211A4 (de) 36 menschliche sekretierte proteine
AU8066998A (en) 86 human secreted proteins
EP1097199A4 (de) 71 humane sekretierte proteine
EP1115735A4 (de) 31 human-sekretierte proteine
EP1124850A4 (de) 12 menschliche sekretierte proteine
EP1027430A4 (de) 64 menschliche sekretierte proteine
EP1032838A4 (de) 125 menschliche sekretierte proteine
EP1009766A4 (de) 19 menschlisch, sekretierte proteine
EP1062236A4 (de) 31 menschliche sekretierte proteine
EP1042674A4 (de) 148 menschliche sekretierte proteine
EP1002132A4 (de) Humane sekretierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000522

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20050202

17Q First examination report despatched

Effective date: 20050628

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CARTER, KENNETH C.

Inventor name: ENDRESS, GREGORY A.

Inventor name: JANAT, FOUAD

Inventor name: DUAN, D. ROXANNE

Inventor name: FLORENCE, CHARLES

Inventor name: FLORENCE, KIMBERLY A.

Inventor name: GREENE, JOHN M.

Inventor name: YOUNG, PAUL

Inventor name: EBNER, REINHARD

Inventor name: SHI, YANGGU

Inventor name: BREWER, LAURIE A.

Inventor name: OLSEN, HENRIK S.

Inventor name: LAFLEUR, DAVID W.

Inventor name: KAYW, HLA

Inventor name: MOORE, PAUL A.

Inventor name: SOPPET, DANIEL R.

Inventor name: WEI, YING-FEI

Inventor name: NI, JIAN

Inventor name: RUBEN, STEVEN M.

Inventor name: ROSEN, CRAIG A.

Inventor name: FENG, PING

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051109